drugset / Trial / NCT00845702

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)

NCT00845702

Phase 3 Terminated 33 enrolled Guerbet
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The study will evaluate the efficacy and safety of Dotarem enhanced MRA compared to TOF MRA in patients suffering from renal arterial disease.

Timeline

Start
2009-04
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadoterate meglumine Diagnostic / imaging agent

Indications